In response to the urgent concern plaguing the pharmaceutical industry, Eminence Business Media has announced the Pharma Impurity Conclave 2023, a symposium dedicated to solving the stubborn challenges by complying with the esteemed pharma fraternity, on the 7th and 8th of September.
While the exhaustive evolution of medicines has led to remarkable breakthroughs, the R&D journey has also encountered numerous challenges, particularly concerning drug impurities. With the advent of various discoveries and synthesis processes, various contaminants have been observed in drug formulations, presenting an array of complex challenges and disputes. However, driven by unwavering determination, the resolute pharma industry has confronted this diversity with remarkable efficiency and precision. Nevertheless, 2018 had a new obstacle in store – NITROSAMINES, which remains the most prominent concern for the industry.
The press release stated that the Pharma Impurity Conclave 2023 aspires to surmount the most widely discussed challenges with unwavering efficacy, offering concrete solutions through in-depth exploration of the various layers of obstacles, thereby fortifying drug impurity profiling practices by evaluating their sources and processes. Though industry professionals are already familiar with multiple mechanisms of identification and risk assessment, the missing piece of the puzzle lies in quantifying uncertainty.
From delving into practical case studies to comprehending the latest guideline updates, this meticulously curated program is designed to address the most recent and pressing challenges concerning impurity mechanisms, adopting cutting-edge and distinctive learning tools. Attendees will have the unique opportunity to learn from distinguished experts and apply their theoretical hypotheses in the stimulating Pharma Impurity Conclave 2023 setting.
Why Attend?
- Interact with your peers and experts and learn about the different mechanisms.
- Case study & live example-based sessions followed by group exercises.
- Dedicated Q&A rounds followed by each session to solve all queries and doubts.
- Benefit from the 6-month support of continuous learning.
- Carefully designed interactive sessions with apt learning tools to enhance holistic mindset
- Networking activities to engage with like-minded individuals and industry leaders.
Who Can Attend?
From managing directors, presidents, vice presidents to senior GMs and mid-level management members, everyone can reap the benefits of this platform to learn and network with industry peers.
DEPARTMENTS
- R&D
- Analytical R&D
- Quality Teams
- Regulatory Teams
- Manufacturing Teams
Tata Chemicals Declares Financial Results
Tata Chemicals Limited has declared its financial results for the quarter ended June 30, 2023. The revenue from operations stood at ₹4,218 crore, as compared to ₹3,995 crore in the corresponding quarter of last year. EBITDA on a consolidated basis, stood at ₹1,043 crore for the quarter, as compared to ₹1,015 crore in for the corresponding quarter of last year. PAT from continuing operations on a consolidated basis, stood at ₹578 crore, for the quarter, as compared to ₹641 crore in for the corresponding quarter of last year.
The press release stated that for the quarter, the revenue stood at ₹1,135 crore, as compared to ₹1,225 crore in for the corresponding quarter of last year. PAT on a standalone basis stood at ₹328 crore, as compared to ₹381 crore for the corresponding quarter of last year. As on 30 June 2023, consolidated gross debt dropped to ₹5,873 crore, as compared to ₹6,296 crore as on 31 March 2023.
Mukundan, Managing Director and CEO, Tata Chemicals Ltd. commented, “The company has delivered a satisfactory performance during Q1FY24 as compared to Q1FY23 despite a challenging environment. The soda ash prices got adversely impacted as many customers delayed their purchasing decisions due to new supplies expected from Inner Mongolia, China. This was further impacted by slower growth in Chinese economy post-COVID and softening of industrial production in developed economies and this may persist in the near term. The Company had to adopt agile pricing to maximize volumes and ensure optimum utilization of capacity. We expect that the sustainability trend will continue to positively impact the demand for newer applications like solar glass and lithium in the medium to long term. Our focus is to ensure that we maintain our market share through customer engagement and continued agile pricing, and to ensure steady contribution margins with focus on costs”.
